Barings’s Idexx Laboratories IDXX Stock Holding History

Barings’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,860	Closed	-$1.12M	–	528
2020 Q3	$1.12M	Sell	2,860 -740	-21%	-$274K	0.03%	313
2020 Q2	$872K	Hold	3,600	–	–	0.03%	306
2020 Q1	$872K	Hold	3,600	–	–	0.03%	306
2019 Q4	$942K	Hold	3,600	–	–	0.03%	377
2019 Q3	$979K	Sell	3,600 -400	-10%	-$111K	0.02%	379
2019 Q2	$1.1M	Buy	+4,000	New	+$986K	0.02%	365
2018 Q4	–	Sell	-8,480	Closed	-$2.12M	–	715
2018 Q3	$2.12M	Hold	8,480	–	–	0.03%	337
2018 Q2	$1.85M	Hold	8,480	–	–	0.03%	375
2018 Q1	$1.62M	Hold	8,480	–	–	0.02%	414
2017 Q4	$1.33M	Hold	8,480	–	–	0.02%	486
2017 Q3	$1.32M	Hold	8,480	–	–	0.02%	413
2017 Q2	$1.37M	Sell	8,480 -5,130	-38%	-$833K	0.04%	403
2017 Q1	$2.1M	Hold	13,610	–	–	0.04%	339
2016 Q4	$1.6M	Hold	13,610	–	–	0.04%	332
2016 Q3	$1.53M	Buy	13,610 +8,010	+143%	+$844K	0.04%	346
2016 Q2	$520K	Buy	+5,600	New	+$481K	0.01%	641

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Barings's IDXX Position: Q4 2020 in Review

Barings sold out of Idexx Laboratories (IDXX) in Q4 2020, closing a stake of 2,860 shares — an estimated $1.12M sold.

Barings first reported a position in IDXX in Q2 2016 and held it in 16 quarters. The position peaked at $2.12M in Q3 2018. 972 funds tracked by Wall St. Rank hold IDXX as of Q4 2020.

Barings reported no remaining Idexx Laboratories position as of Q4 2020 after selling out during the quarter.
Barings sold 2,860 Idexx Laboratories shares in Q4 2020, an estimated $1.12M.
Barings first reported a position in Idexx Laboratories in Q2 2016 and held it in 16 quarters.
Barings's Idexx Laboratories position peaked at $2.12M in Q3 2018.
972 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2020.

Based on Barings's 13F filing for Q4 2020, filed 16 Feb 2021.